IACS-010759
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IACS-010759, covering 2023-06-15 to 2023-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]